Cosmetic cross-reference Noindex: medium evidence

2835-99-6

CAS 2835-99-6

2835-99-6 (CAS 2835-99-6) is a pharmaceutical compound with 0 bioactivity targets and 0 adverse event associations.

SOURCE NLM DailyMed
Label records
0
SOURCE EMBL-EBI ChEMBL
Bioactivity
0
SOURCE DrugCentral
Adverse signals
0
SOURCE IUPHAR/BPS
PubMed IDs
0
SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name
2835-99-6
CAS Number
2835-99-6
UNII
12R07I1K8C
InChIKey
QGNGOGOOPUYKMC-UHFFFAOYSA-N
ChEMBL ID
CHEMBL3092390
Molecule Type
Small molecule
Source Match
EMBL-EBI ChEMBL (INCHIKEY)
SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is 2835-99-6 used for in pharmaceutical contexts?

2835-99-6 (CAS 2835-99-6) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for 2835-99-6?

No adverse-event association or SIDER side-effect rows are rendered for 2835-99-6 in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is 2835-99-6 also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for 4-Amino-M-Cresol with EU status "prohibited".

What clinical phase is 2835-99-6 in?

No phase 1-4 clinical development badge is rendered for 2835-99-6 because the matched compound identifier rows do not contain a max-phase value.